In patients with type 2 diabetes and cirrhosis, SGLT2 inhibitors show increased efficacy over DPP-4 inhibitors in kidney, cardiac, and liver outcomes. SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors, ...

Understanding the Context

The Times of India on MSN: Silent killer of the liver: How lifestyle changes and early screening can prevent cirrhosis before it’s too late Health care professionals are now recognizing liver cirrhosis cases in people who seldom consume alcohol, linking this trend to modern lifestyle choices such as inadequate nutrition, excessive weight, ... Silent killer of the liver: How lifestyle changes and early screening can prevent cirrhosis before it’s too late The etiology of liver cirrhosis has transformed from hepatitis B virus-driven to metabolic dysfunction-associated steatotic liver disease (MASLD). In ... Liver cirrhosis is a serious condition where long-term damage causes the liver to shrink and its cells to die.

Key Insights

Common triggers include heavy drinking, Hepatitis B or C, and fatty liver disease. While ... STAT: Bariatric surgery halted progression of liver disease in patients with obesity and cirrhosis, study finds Bariatric surgery halted progression of liver disease in patients with obesity and cirrhosis, study finds News Medical: Bariatric surgery reduces liver complications in obese patients with cirrhosis A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver ... Cirrhosis is the result of long-term liver injury where healthy tissue is replaced with scar tissue (fibrosis). Common causes of cirrhosis include alcohol use disorder (AUD), nonalcoholic fatty liver ...

Final Thoughts